Atria Investments Inc Reduces Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Atria Investments Inc reduced its position in The Cooper Companies, Inc. (NASDAQ:COO) by 1.6% in the 3rd quarter, Holdings Channel reports. The firm owned 44,168 shares of the medical device company’s stock after selling 710 shares during the period. Atria Investments Inc’s holdings in Cooper Companies were worth $4,873,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in COO. Covestor Ltd increased its position in Cooper Companies by 305.9% in the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after acquiring an additional 208 shares during the period. Innealta Capital LLC purchased a new stake in shares of Cooper Companies during the second quarter worth approximately $25,000. Crewe Advisors LLC lifted its holdings in shares of Cooper Companies by 286.4% during the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after purchasing an additional 252 shares during the period. Clearstead Trust LLC purchased a new position in Cooper Companies in the 1st quarter valued at $36,000. Finally, Tortoise Investment Management LLC increased its stake in Cooper Companies by 75.4% in the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock valued at $34,000 after buying an additional 169 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Cooper Companies stock opened at $102.00 on Wednesday. The firm has a market capitalization of $20.31 billion, a PE ratio of 56.82, a P/E/G ratio of 2.24 and a beta of 0.99. The Cooper Companies, Inc. has a 52 week low of $81.99 and a 52 week high of $112.38. The firm’s 50-day simple moving average is $107.18 and its 200 day simple moving average is $97.82. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. During the same period in the prior year, the business earned $0.84 earnings per share. The company’s quarterly revenue was up 7.8% on a year-over-year basis. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently commented on COO shares. StockNews.com upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Friday, November 8th. Wells Fargo & Company raised their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Morgan Stanley boosted their target price on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 10th. Stifel Nicolaus reissued a “buy” rating and issued a $115.00 price target (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Insider Transactions at Cooper Companies

In related news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now owns 165,273 shares of the company’s stock, valued at $18,267,624.69. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Cooper Companies news, CFO Brian G. Andrews sold 24,788 shares of the stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the transaction, the chief financial officer now owns 6,614 shares of the company’s stock, valued at $700,422.60. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock valued at $27,637,427 over the last three months. 2.00% of the stock is currently owned by insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.